MTNB
Matinas BioPharma Holdings Inc
NYSE MKT: MTNB · HEALTHCARE · BIOTECHNOLOGY
$0.61
+2.87% today
Updated 2026-04-29
Market cap
$3.91M
P/E ratio
—
P/S ratio
34.81x
EPS (TTM)
$-2.00
Dividend yield
—
52W range
$0 – $3
Volume
0.0M
Matinas BioPharma Holdings Inc (MTNB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-3.8%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+62.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.9%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-6.3%
2025-11-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-26 | $-0.30 | — | $0.57 | $0.56 | -1.6% |
| 2025-11-10 | $-0.40 | — | $1.28 | $1.20 | -6.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $-0.30 | — | — | — |
| 2025-09-30 | — | $-0.40 | — | — | — |
| 2025-06-30 | — | $-1.03 | — | — | — |
| 2025-03-31 | $-0.78 | $-0.81 | -3.8% | $962000.00 | — |
| 2024-12-31 | $-0.78 | $-0.81 | -3.3% | — | — |
| 2024-09-30 | $-1.05 | $-0.85 | +19.0% | — | — |
| 2024-06-30 | $-0.02 | $-0.02 | +0.0% | — | — |
| 2024-03-31 | $-0.03 | $-0.03 | +0.0% | — | — |
| 2023-12-31 | $-0.03 | $-0.02 | +33.3% | $-1.10M | — |
| 2023-09-30 | $-0.03 | $-0.03 | +0.0% | — | — |
| 2023-06-30 | $-0.03 | $-0.03 | +0.0% | — | — |
| 2023-03-31 | $-0.03 | $-0.03 | +0.0% | $1.10M | — |
Frequently asked questions
Has Matinas BioPharma Holdings Inc beaten earnings estimates?
Matinas BioPharma Holdings Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -3.8% over the last 1 quarters.
How does MTNB stock react to earnings?
MTNB stock has moved an average of -3.9% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.